Skip to content
411 PRESS
WarningRecall #D-0487-2026Drug / Pharmaceutical

Island Kinetics Recalls Blemish Spot Treatment (Salicylic Acid) 1%

Island Kinetics, Inc. d.b.a. CoValence Laboratories · Class II — Moderate Risk

Assorted pharmaceutical pills and tablets — representative photo for FDA drug recall
An assortment of pharmaceutical pills (representative file photo). Specific recalled product: see recall details below. Photo: Michael Nutt / Wikimedia Commons (CC BY-SA 2.0).

Product Description

Blemish Spot Treatment (Salicylic Acid) 1%, .5 fl oz (15 ml) bottles, Skin Script, Chandler, AZ 85226, UPC 6 10563 13873 9.

Reason for Recall

Failed Stability Specifications

FDA Classification

Class II — Moderate Risk

A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

Distribution

U.S. Nationwide

Remedy

Consumers should stop using this product. Contact the recalling firm for further instructions regarding this product.

Independent news on labor, safety, and accountability.